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 Objective To review the results of vaginal hysterectomies in patients 
without uterine prolapse.
 Design Retrospective chart review.
 Setting University affiliated hospital, Hong Kong.
 Patients All patients who had vaginal hysterectomies in the absence of 
uterine prolapse from 1999 to 2005 inclusive (first period) and 
2006 to 2009 inclusive (second period).
 Main outcome measures The number of such hysterectomies, indications, operative 
procedures, complications, use of preoperative gonadotropin-
releasing hormone agonist, and concomitant vaginal salpingo-
oophorectomies performed.
 Results In all, 94 and 98 patients fulfilling the necessary inclusion 
criteria within the two respective periods underwent vaginal 
hysterectomy. The indications for hysterectomy in the respective 
groups were similar, and 89 (95%) and 90 (92%) of the patients 
were Chinese. The respective proportions having additional 
procedures were 11% versus 23% (P=0.018) and the respective 
vaginal bilateral salpingo-oophorectomy rates were 1% versus 
15% (P<0.001). The vault haematoma rate decreased significantly 
in the second period (from 12% to 1%; P=0.002). There were no 
significant differences between the periods with respect to mean 
operative blood losses, uterine weights, and operating times. 
The use of gonadotropin-releasing hormone agonist resulted 
in reduced mean uterine sizes (12 weeks vs 10 weeks; P=0.041). 
A decreasing trend in mean operating times and blood losses 
was also observed after such use. Vaginal hysterectomy and 
bilateral salpingo-oophorectomies were successfully performed 
in 12 (80%) patients without laparoscopic assistance. For this 
procedure, a learning curve was also evident.
 Conclusions Surgeons’ experience can influence the complication rate and 
the chance of successful vaginal salpingo-oophorectomy. More 
liberal use of gonadotropin-releasing hormone agonist may 
further reduce the complication rate and allow more vaginal 
hysterectomies.
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Introduction
Hysterectomy is a commonly performed major procedure. The preferred route of 
hysterectomy should be vaginal, whenever feasible.1,2 When compared with all hysterectomies 
for benign indications, in different countries the proportion of vaginal hysterectomies 
varies from 23% to 55%.3 Based on territory-wide audits published by the Hong Kong 
College of Obstetricians and Gynaecologists,4 the proportions of vaginal hysterectomies 
New knowledge added by this study
• This study confirms that vault haematoma can be prevented by experienced surgeons and by 
paying particular attention to potential ‘bleeders’ at ‘four- and eight-o’clock regions’.
• Our study confirms the feasibility of introducing vaginal hysterectomy for patients without 
uterine prolapse, by undertaking laparoscopy-assisted procedures.
Implications for clinical practice or policy
• Use of gonadotropin-releasing hormone agonist in these patients may reduce complication 
rates and increase the number of suitable candidates for this operation.
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performed locally in 1999 and 2004 were estimated 
to be 13.1% and 11.8%, respectively. Most of the 
vaginal hysterectomies performed in these years 
(75.1% and 82.9%, respectively) were for patients 
with genital prolapse.4 These estimates were derived 
by dividing the numbers of vaginal hysterectomies 
with pelvic floor repair (338 and 420, respectively) by 
the total number of vaginal hysterectomies (450 and 
507, respectively). In our department, until 1995, the 
vaginal route was rarely chosen for patients without 
genital prolapse. In that year, we performed our 
first laparoscopically assisted vaginal hysterectomy 
(LAVH). From 1995 to 1998, 93 LAVHs were performed. 
We performed our first vaginal hysterectomy on a 
patient without genital prolapse in 1999. Our first 
series (from 1999 to 2005) was reported in 2007.5 
Here we review our subsequent series, and share 
our experience introducing the technique of vaginal 
hysterectomy for patients without genital prolapse.
	 目的	 探討為無子宮脫垂的患者進行下陰式子宮切除術的結
果。
	 設計	 回顧研究。
	 安排	 香港一所大學附屬醫院。
	 患者	 1999至2005年（第一階段）以及2006至2009年（第
二階段）期間，所有進行下陰式子宮切除術的無子宮
脫垂患者。
	主要結果測量	 進行子宮切除術的次數、適應症、手術方式、併發
症、手術前促性腺激素釋放素激動劑的使用，以及同
時進行的經陰道輸卵管卵巢切除術。
	 結果	 第一及第二階段中分別有94名和98名合乎研究標準
的患者進行下陰式子宮切除術。兩組的子宮切除術
適應症相似，並分別有89名（95%）和90名（92%）
為華籍患者。兩組中要額外進行手術的比例為11%及
23%（P=0.018），其進行雙側經陰道輸卵管卵巢切
除術的比例為1%及15%（P<0.001）。第二階段患者
的血腫率顯著減少，由12%下降至1%（P=0.002）。
兩組間在術中失血、子宮重量和手術時間方面並無顯
著分別。促性腺激素釋放素激動劑的使用令子宮縮小
（12週比10週；P=0.041），也縮短手術時間及減少
術中失血量。在無腹腔鏡協助的情況下，成功為12名
（80%）患者進行下陰式子宮切除術及雙側經陰道輸
卵管卵巢切除術。這些技術明顯存在着學習曲線的規
律。
	 結論	 外科醫生的經驗可以影響併發症發生率以及經陰道輸
卵管卵巢切除術的成功率。多用促性腺激素釋放素激
動劑或可進一步降低併發症發生率，並增加陰道子宮
切除術的可行性。
為無子宮脫垂的患者進行下陰式子宮切除術： 
十年工作經驗分享
Methods
Queen Mary Hospital is a university-affiliated facility 
serving the population of Hong Kong Island West. 
A retrospective chart review was performed for 
all patients who had vaginal hysterectomies in the 
absence of genital prolapse carried out in the inclusive 
periods 1999-2005 and 2006-2009. Corresponding 
subjects were identified using scheduled elective 
operation lists in the computerised clinical database 
(Clinical Management System, Hospital Authority, 
Hong Kong), and those scheduled for vaginal 
hysterectomy were identified. Information on the 
indications, operative procedures, and complications 
was extracted and analysed. Vaginal hysterectomy 
was offered for patients with a uterine size equivalent 
to a pregnancy of less than 12 weeks and unrestricted 
uterine mobility.6 Because of the retrospective 
nature of this study however, the actual number of 
suitable patients not offered or who refused this 
option could not be determined. Since 2006, if the 
uterine size was larger than or equal to 12 weeks, 
the patient was given a gonadotropin-releasing 
hormone agonist (GnRHa) injection intramuscularly 
(11.25 mg leuprorelin acetate) 3 months prior to the 
operation. Vaginal hysterectomies were performed as 
previously described5 under general anaesthesia with 
prophylactic antibiotics being given at induction. If 
bilateral salpingo-oophorectomies were to be done, 
the infundibulopelvic ligaments were clamped as 
close to and as medial as possible to the ovary. The 
ovary and tube were severed and the pedicles double-
ligated.7 Quantitative data were analysed using the 
Statistical Package for the Social Sciences (Windows 
version 18.0; SPSS Inc, Chicago [IL], US). Student’s t 
tests were used for continuous variables that were 
normally distributed and the Mann-Whitney U test 
was used for skewed data. Chi squared or Fisher’s 
exact tests were used for dichotomous outcomes. 
Results were considered significant when the P value 
was <0.05. The study protocol was approved by the 
Institutional Review Boards of the University of Hong 
Kong and the Hospital Authority (Hong Kong West 
Cluster). 
Results
The different indications for hysterectomies 
performed in our department for benign diseases 
from 1999 to 2005 and 2006 to 2009 are listed in Table 
1. Demographic data pertaining to these two patient 
groups are listed in Table 2. In the first period, seven 
gynaecologists including trainees under supervision 
carried out a total of 94 vaginal hysterectomies 
in patients without genital prolapse. Six of these 
gynaecologists with one new trainee carried out 
a total of 98 vaginal hysterectomies in the second 
period. Apart from vaginal hysterectomies, 10 and 
23 patients, respectively had additional procedures 
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(P=0.018). In the second period, there were 15 
concomitant bilateral salpingo-oophorectomies. 
Regarding the remaining eight procedures, they 
entailed excision of incidental fimbrial (paraovarian) 
cysts (n=4); laparoscopic left salpingo-oophorectomy 
for a left ovarian fibroma; removal of the Hulka clip 
for a previous tubal occlusion; marsupialisation 
for a Bartholin’s cyst and breast mass excision; and 
laparoscopic repair of an operative bladder injury. 
Respectively in the two periods, conversion rates to 
laparotomy were similar (1% vs 2%), 2 and 14 patients 
had conversions to laparoscopy, 1 and 2 to laparotomy, 
and 8 and 1 did not receive prophylactic antibiotics. 
The uterus was removed intact in 11 and 12 patients, 
respectively. The remaining patients underwent 
removal of the uterus, sometimes combined with 
bisection, morcellation, or myomectomy. A drain 
was inserted at the end of the procedure in 24 and 
21 patients, respectively. In all, 32 and 19 patients did 
not take any analgesics after their operations. Median 
hospital stays were 3 days in both periods; 9 and 6 
patients stayed longer than 5 days, respectively. Table 
3 lists complications related to the procedure. The 
rate of vault haematoma development decreased 
TABLE 1.  Preoperative diagnoses
Preoperative diagnoses No. (%) of patients
1999-2005 (n=94) 2006-2009 (n=98)
Uterine fibroid 77 (82) 80 (82)
Adenomyosis 5 (5) 5 (5)
Microinvasive carcinoma of cervix/cervical intraepithelial neoplasia 6 (6) 6 (6)
Dysfunctional uterine bleeding 3 (3) 4 (4)
Endometrial hyperplasia 1 (1) 1 (1)
Other 2 (2) 2 (2)
TABLE 2.  Demographic data
Demographics* 1999-2005 (n=94) 2006-2009 (n=98) P value
Median (range) age (years) 44 (39-62) 46 (37-71) 0.001
No. of Chinese patients 89 (95%) 90 (92%) -
No. with previous LSCS 18 25 0.061
One 13 13
Two 3 12
Three 2 0
No. with previous LEEP or cone biopsy 6 5 0.703
Median (range) uterine size (weeks) 8 (4-12) 10 (6-18) <0.001
Mean (range) operative blood loss (mL) 334 (50-2000) 427 (50-2820) 0.522
Mean (range) uterine weight (g) 226 (40-504) 245 (23-670) 0.308
Mean (range) operating time (mins) 77 (35-197) 91 (35-290) 0.056
Additional procedures 10 (11%) Patients (1 prophylactic 
salpingo-oophorectomy)
23 (23%) Patients (15 prophylactic 
salpingo-oophorectomies)
0.018 (<0.001†)
Conversion to laparoscopy/laparotomy 3 (3%) 16 (16%) 0.003
Laparoscopy 1 For haemostasis 
1 For ovarian cyst
3 For haemostasis 
4 For pelvic adhesions 
6 Due to no uterine descent 
1 For ovarian cyst
-
Laparotomy 1 For haemostasis 1 For haemostasis 
1 For limited vaginal access
-
* LSCS denotes lower segment caesarean section, and LEEP loop electrosurgical excision procedure
† This is the P value for patients having vaginal bilateral salpingo-oophorectomies
TABLE 3.  Complication rates with vaginal hysterectomy
Complication 1999-2005 
(n=94)
2006-2009 
(n=98)
P value
Unexplained fever 4 (4) 3 (3) 0.659
Bowel injury 0 (0) 0 (0) -
Bladder injury 3 (3) 1 (1) 0.292
Transfusion rate 9 (10) 8 (8) 0.731
Vault haematoma 11 (12) 1 (1) 0.002
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significantly in the second period (from 12% to 1%; 
P=0.002). In the second period, there were 40 patients 
with preoperative uterine sizes equal to or larger 
than 12 weeks of gestation (Table 4). In all, 21 patients 
received preoperative GnRHa 3 months prior to the 
operation. Table 4 also shows uterine sizes, operation 
durations, blood loss volumes, and complication rates 
in recipients and non-recipients of this treatment. 
 Only one concomitant bilateral salpingo-
oophorectomy was performed in the first period. 
Bilateral vaginal salpingo-oophorectomies were 
performed in 15 patients in the second period (Table 
5); laparoscopic assistance was resorted to for three 
of these. All adnexae looked normal at the time of 
operation, except that one patient had bilateral 
2-cm endometriotic cysts, for which conversion to 
laparoscopy was deemed necessary due to pelvic 
adhesion encountered during vaginal hysterectomy. 
In all, 12 procedures were carried out by the most 
experienced surgeon, with only one conversion to 
laparoscopic assistance (due to pelvic adhesions 
resulting from endometriosis). Three procedures 
were by another surgeon, with two conversions to 
laparoscopic assistance (due to pelvic adhesions and 
a fibroid over the anterior wall close to the cervix).
Discussion
In our previous report,5 we observed that the 
surgeon’s experience was an important factor in 
reducing complications. In particular, attention to 
‘bleeders’ at the ‘four- and eight-o’clock regions’ 
reduced the frequency of vault haematomas. We 
suggested that use of GnRHa may increase the 
chance of successful vaginal hysterectomy.
 The importance of the surgeon’s experience 
was confirmed in the current series. Three bladder 
injuries occurred in the first period, all within the 
first 10 cases operated on by the respective surgeon. 
Only one bladder injury occurred in the second 
period. The patient had had a prior appendectomy 
and two previous lower segment caesarean sections. 
The uterine size was 12 weeks and GnRHa was not 
given. Similarly, the frequency of vault haematomas 
decreased significantly from 12% to 1% (P=0.002). 
There was no difference in postoperative management 
in these two periods. Any decision to investigate for 
the presence of a vault haematoma depended on the 
attending doctor’s clinical suspicions, often based on 
a decrease in haemoglobin level, fever, or detection 
of a pelvic mass. There was no postoperative 
haemorrhage warranting a second operation in the 
second period, whilst there were three in the first 
period. There were no significant differences in 
mean operative blood losses, uterine weights, or 
operating times, though more additional procedures 
were performed in the second period.
 We started using preoperative GnRHa in 2006, 
and about half of our patients (with uterine size of 
≥12 weeks of gestation) received such injections. 
The use of GnRHa resulted in a reduction in mean 
uterine size in the second period (12 weeks vs 10 
weeks; P=0.041). A trend towards a decrease in 
operating time and blood loss was also evident after 
its use. With more liberal use of GnRHa, the number 
TABLE 4.  Preoperative gonadotropin-releasing hormone agonist (GnRHa) use in patients having a uterus equal to or larger than 12 weeks of gestation
GnRHa not given (n=19) GnRHa given* (n=21) P value
Median (range) uterine size during operation (weeks) 12 (12) 10 (8-18) 0.041
Mean (range) duration of operation (mins) 107 (44-290) 93 (44-199) 0.915
Mean (range) intra-operative blood loss (mL) 695 (50-2000) 413 (100-950) 0.347
Transfusion rate 3/19 (16%) 3/21 (14%) 0.894
Bladder injury 1/19 (5%) 0/21 (0%) 0.287
Conversion to laparoscopy/laparotomy 6/19 (32%)
1 Laparoscopy for haemostasis
3 Laparoscopic assistance for no 
descent
2 Laparoscopic assistance for intra-
abdominal adhesion
4/21 (19%)
1 Laparoscopy for haemostasis
1 Laparoscopic assistance for no 
descent
1 Laparoscopic assistance for intra-
abdominal adhesion
1 Laparotomy due to limited vaginal 
access†
0.361
* Leuprorelin acetate (11.25 mg) was given 3 months prior to the operation
† Never sexually active
TABLE 5.  Vaginal hysterectomy with bilateral salpingo-oophorectomies during 2006-
2009
Data
No. of patients 15/98 (15%)
Median (range) uterine size during operation (weeks) 10 (6-18)
Mean (range) duration of operation (mins) 112 (53-195)
Mean (range) intra-operative blood loss (mL) 485 (50-2000)
No. of conversion to laparoscopy 3/15 (20%)
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of vaginal hysterectomies may increase further and 
complication rates may diminish further.
 Only one bilateral salpingo-oophorectomy was 
performed in the first period. In the second period, 
salpingo-oophorectomies were attempted in 15 
patients, and successfully completed vaginally in 12 
(80%) of the patients. The most experienced surgeon 
performed the procedure on 12 patients with only 
one conversion. Another surgeon performed the 
remaining three procedures with two conversions, 
possibly reflecting the importance of the surgeon’s 
experience.
 It was suggested that introduction of LAVH into 
gynaecology training could increase the confidence 
and skill of surgeons performing this intervention,8 
though we cannot identify any publication to support 
this suggestion. We managed to introduce vaginal 
hysterectomies for patients without genital prolapse 
by starting with LAVH. The vaginal part of LAVH is 
the same as that for vaginal hysterectomies. We 
also learned to remove the uterus after its bisection 
or morcellation when we performed LAVH. In our 
experience, the uterus could be removed intact only 
in about 10% of our patients. In retrospect, it seems 
that performance of LAVH is an important step 
before the introduction of vaginal hysterectomies 
on patients without genital prolapse. After mastering 
the technique, LAVH should be reserved for patients 
for whom laparoscopy can produce an advantage, 
for example by allowing thorough intraperitoneal 
adhesion assessment and subsequent adhesiolysis. 
 Interestingly, more than 90% of our patients 
were Chinese, but information in the English 
literature on vaginal hysterectomies without prolapse 
in this patient group was minimal. Our findings 
demonstrate that the introduction of the procedure 
appeared equally applicable to the Chinese.
 This was a retrospective study comparing appli-
cation of the same technique in two different time 
periods. Thus, the inconsistent use of preoperative 
GnRHa may have affected the complication rate. 
The median uterine size was larger in the second 
period (8 weeks vs 10 weeks; P<0.001). Patients with 
borderline uterine size may not receive preoperative 
GnRHa before attempting vaginal hysterectomy. This 
too may explain the increased conversion rate to 
laparoscopy in the second period. 
Conclusions
We believe that LAVH is a useful preliminary 
step to developing the skills needed for vaginal 
hysterectomies in patients without uterine prolapse. 
The frequency of complications can be reduced 
with experience. The use of GnRHa may reduce 
the complication rate and increase the number 
of suitable candidates for this operation. Vaginal 
bilateral salpingo-oophorectomies can be introduced 
at a later date when more experience is accumulated.
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